Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel

Rinat Cohen-Moreno, Miriam Schiff, Shabtay Levitt, Rachel Bar-Hamburger, Shiela Strauss, Yehuda Neumark

Research output: Contribution to journalArticlepeer-review


Ignorance about Hepatitis-C (HCV) among drug users, treatment staff, and policy makers thwarts treatment uptake and facilitates virus transmission. We assessed knowledge about HCV among methadone patients in Israel, where effective HCV-treatment is provided at low-cost within the national health insurance framework, yet few infected methadone patients are treated. In 2006, 512 patients in two methadone clinics in Israel were interviewed, of whom 53% were HCV-positive. The clinics were purposively selected from the 11 methadone clinics in the country. Respondents exhibited poor knowledge about HCV, particularly about diagnosis and treatment. Lesser-educated respondents were three times more likely to score low on HCV-knowledge compared to those with 12+ years of schooling (AOR = 2.97, 95 CI = 1.55.7. HCV-negative patients were also three-times more likely than HCV-positive patients to score low on the HCV-knowledge scale (Adjusted Odds Ratio = 3.0, 95% Confidence Interval = 1.94.7). Enhancing HCV-knowledge may help patients avoid becoming infected and infecting others, allay exaggerated fears about hepatitis, and facilitate HCV-treatment initiation among those infected.

Original languageEnglish (US)
Pages (from-to)58-76
Number of pages19
JournalSubstance Use and Misuse
Issue number1-2
StatePublished - 2010


  • Drug dependence
  • HCV
  • Hepatitis C
  • Knowledge
  • Methadone

ASJC Scopus subject areas

  • Health(social science)
  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health


Dive into the research topics of 'Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel'. Together they form a unique fingerprint.

Cite this